AbbVie Inc (ABBV)

Industry Drug Manufacturers - General

This stock can be held in an Investment ISA and an Investment Account
Sell

$190.75

Buy

$193.50

arrow-down$-1.76 (-0.90%)

AbbVie Inc is a biopharmaceutical company that discovers, develops, manufactures and sells a range of pharmaceutical products for treating chronic autoimmune diseases, virology and neurological disorders.
Prices updated at 01 May 2025, 22:10 EDT
| Prices minimum 15 mins delay
|
Prices in USD

Most recent dividend payment

1.640
Cash Dividend
15 Apr 2025
13 Feb 2025
15 Apr 2025
15 May 2025

Total dividend yield

Created with Highcharts 7.2.2Total yield (%)Total yield (%)20212022202320242025012345

Dividend history and forecast data table

YearDividend per shareDividend growth (%)
20253.2800-
20246.20000.05
20235.92000.05
20225.64000.08
20215.20000.10
20204.72000.10
20194.28000.19
20183.59000.40
20172.56000.12
20162.28000.13

Total dividend yield data table

YearDividend yield (%)Buyback yield (%)Total yield (%)
20253.000.463.46
20243.490.433.92
20233.820.724.54
20223.490.564.05
20213.840.464.30
20204.410.364.77
20194.832.056.88
20183.897.6711.56
20172.651.764.41
20163.645.348.98

Dividend per share

Created with Highcharts 7.2.2Dividend per shareDividend per share2021202220232024202502468

% of earnings paid to shareholders

Created with Highcharts 7.2.2Payout ratio (%)Payout ratio (%)202120222023202420250100200300

Dividend per share data table

YearDividend per share
20253.2800
20246.2000
20235.9200
20225.6400
20215.2000
20204.7200
20194.2800
20183.5900
20172.5600
20162.2800

% of earnings paid to shareholders data table

YearPayout ratio (%)
2025259.41
2024213.59
2023160.27
202273.73
2021122.71
202099.35
2019183.70
201867.84
201760.44
201660.00
Latest Financial Report as of 30 Apr 2025
Dividend amount and dividend per share are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.